Aspirin vs Clopidogrel
Clinical Comparison
Clinical Context
Aspirin is the first-line antiplatelet for secondary cardiovascular prevention. Clopidogrel is used as an alternative when aspirin is contraindicated, or in combination with aspirin as DAPT post-ACS or post-PCI. The CAPRIE trial showed clopidogrel marginally superior to aspirin for the composite endpoint of MI, stroke, and vascular death.
Drug Profiles
Aspirin
Non-selective COX inhibitor / antiplatelet
Mechanism
Irreversibly acetylates COX-1, blocking thromboxane A2 synthesis and permanently inhibiting platelet aggregation for the lifespan of the platelet (7-10 days)
Indications
- Secondary prevention of cardiovascular disease (post-MI, post-stroke)
- Acute coronary syndrome (loading dose)
- Dual antiplatelet therapy (with clopidogrel or ticagrelor)
- Kawasaki disease
Common Doses
75 mg OD (secondary prevention); 300 mg loading dose in ACS
Route
Oral
Onset & Duration
Onset 30-60 min; irreversible platelet inhibition lasting 7-10 days
Clopidogrel
Thienopyridine antiplatelet agent
Mechanism
Irreversibly inhibits the P2Y12 ADP receptor on platelets after hepatic CYP2C19 activation (prodrug)
Indications
- Secondary prevention post-MI, ischaemic stroke, or PAD
- Dual antiplatelet therapy (with aspirin post-ACS/PCI)
- Alternative to aspirin when aspirin is contraindicated
Common Doses
75 mg OD maintenance; 300-600 mg loading dose
Route
Oral
Onset & Duration
Onset 2 hours (loading dose); irreversible platelet inhibition lasting 7-10 days
Key Differences
| Category | Aspirin | Clopidogrel |
|---|---|---|
| Mechanism | COX-1 inhibition (blocks thromboxane A2) | P2Y12 ADP receptor inhibition (prodrug) |
| GI bleeding risk | Higher — direct GI mucosal damage | Lower — no direct GI mucosal effect |
| NICE first-line position | First-line for secondary CV prevention | Alternative when aspirin is contraindicated |
| Pharmacogenomic variability | Consistent — no metaboliser-dependent efficacy | CYP2C19 poor metabolisers: reduced efficacy |
| Stroke prevention | Used but aspirin + dipyridamole was traditional | NICE first-line monotherapy for secondary stroke prevention |
| Cost | Extremely cheap (<1p per tablet) | Cheap but more expensive than aspirin |
Mechanism
COX-1 inhibition (blocks thromboxane A2)
P2Y12 ADP receptor inhibition (prodrug)
GI bleeding risk
Higher — direct GI mucosal damage
Lower — no direct GI mucosal effect
NICE first-line position
First-line for secondary CV prevention
Alternative when aspirin is contraindicated
Pharmacogenomic variability
Consistent — no metaboliser-dependent efficacy
CYP2C19 poor metabolisers: reduced efficacy
Stroke prevention
Used but aspirin + dipyridamole was traditional
NICE first-line monotherapy for secondary stroke prevention
Cost
Extremely cheap (<1p per tablet)
Cheap but more expensive than aspirin
Key Advantages
Aspirin
- Cheapest antiplatelet agent available
- Decades of evidence (ISIS-2, CURE trials)
- Universal first-line for secondary CV prevention
- Dual role in ACS (antiplatelet + anti-inflammatory)
Clopidogrel
- Alternative when aspirin is contraindicated or not tolerated
- Lower GI bleeding risk than aspirin
- Proven efficacy in stroke and PAD (CAPRIE trial)
- No GI ulceration effect (different mechanism)
- Used in combination with aspirin for enhanced antiplatelet effect
Key Cautions
Aspirin
- GI bleeding and ulceration (co-prescribe PPI if high risk)
- No proven benefit for primary prevention in most patients
- Aspirin-exacerbated respiratory disease (Samter's triad)
- Reye syndrome risk in children under 16
- Avoid in active peptic ulcer disease
Clopidogrel
- CYP2C19 poor metabolisers — reduced efficacy
- Avoid omeprazole co-prescription (use lansoprazole instead)
- Stop 7 days before elective surgery
- Higher cost than aspirin
- Prodrug variability
Clinical Verdict
Aspirin 75 mg is first-line for secondary cardiovascular prevention. Clopidogrel is the alternative when aspirin is contraindicated (allergy, GI intolerance) and is NICE first-line for secondary stroke prevention. Both are combined as DAPT post-ACS/PCI.
Medical Disclaimer: This comparison is for educational purposes only and is not a substitute for professional medical advice. Always consult a qualified healthcare professional before making prescribing decisions. Verify all drug information with current clinical guidelines (BNF, NICE, SmPCs).
Full monographs for Aspirin & Clopidogrel in the MedNext app
Complete dosing, interactions, contraindications, side effects, and more — covering 2,866 drugs with AI-powered search.
Download MedNext Formulary